companydata.dkAbacus Medicine Pharmaceuticals ApS: Financial statements 2019
CVR: 39192063
Abacus Medicine Pharmaceuticals ApS (CVR 39192063) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -212,160 and a net result of DKK 547,639 compared with DKK 860,434 the year before. Equity amounted to DKK 15,883,824. The solvency ratio was 70.3%.
- Gross Profit
- -212,160 kr.
- Profit/Loss
- 547,639 kr.
- Equity
- 15,883,824 kr.
- Total Assets
- 22,586,280 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -212 t. | 548 t. | 15.9 mio. | 0 |
| 2018 | - | -62 t. | 860 t. | 15.3 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
Abacus Medicine Pharmaceuticals ApS has published its annual report for 2018. Gross profit came to DKK -61,772, and the net result was DKK 860,434.
About Abacus Medicine Pharmaceuticals ApS
Abacus Medicine Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2017. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Wagner. The company is owned by ABACUS MEDICINE A/S. In 2025, the company reported a gross profit of DKK -80,000 and a net result of DKK -5,483,000 compared with DKK -2,436,000 the year before. Equity amounted to DKK 14,264,000.